Company name: Translational Life Sciences
Description: Developer of proprietary formulations that contain restricted substances such as psilocybin and cannabis to serve unmet medical needs in the market. The company offers research services to treat opioid dependence, psychotic illness, pain management and traumatic brain injuries such as concussions.
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million): 0.75
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: A 18% stake in the company was acquired by Flourish Mushroom Labs Inc. for $750000 on February 6, 2020.
Number of active investors:
Profile last updated: 25-Mar-2020
Last known valuation:
Last known valuation date: 06-Feb-2020